4 ms·
Most drugs are expensive because it costs a lot to develop them and it's getting more expensive. It costs a lot to develop them because it's hard to predict wha
by aaavl2821 8y ago
Most drugs are expensive because it costs a lot to develop them and it's getting more expensive. It costs a lot to develop them because it's hard to predict what drugs will work until you test them in humans. It can cost over $100-200M just to do human proof of concept studies, and almost 70% of drugs fail at this stage
Most r&d is done by pharma companies, not academia. $200B spent by Pharma in r&d each year, probably half of that is early stage. NIH spends $30B or so, and most of that is basic research that will never lead to a new drug. Without patents there would be zero new drugs developed
r&d productivity is approaching 0% by some estimates (deloitte, McKinsey and a Novartis analysis). Pharma cannot generate enough new drugs to sustain growth. So they increase prices. Over 60% of revenue growth of major drugs came from price hikes the last few years (per 2018 year in rev presentation by atlas venture)
This is bad. There are many instances of egregious price hikes for drugs that are quite old. But payers have been fighting this quite effectively of late and have restricted pricing growth to the rate of inflation the last couple years
There are 3 PBMs that control most of the market. They extract rebates and don't pass them along to consumers. Copays for drugs are often more restrictive than for medical procedures. There's an argument that access, i.e. High copays, is a bigger challenge than price in some cases (but not all)
There are also just greedy people like Martin shkrei and epipen / Mylan. But they are outliers exploiting a few FDA loopholes
Over 60% of drugs today are developed by small companies (as opposed to big pharma). These companies are an order of magnitude more efficient than Pharma at r&d. The medicines they develop will be expensive but in many cases are designed to be cost effective at ~$100k / QALY.
There is a certain point where it will no longer be cost effective to develop new drugs. We are probably approaching that point barring either technological breakthroughs or a reduction in cost of developing drugs (i.e. Looser FDA)
Drugs are expensive. They are also only 10% of national health expenditure and like 80% of prescriptions are generic. They are a pretty great tool to fight disease
It's a really complex issue